|
|
Article: Algos Attracts CRO Veteran Dr. Ganesh Iyer as its New CEO.
- Article from:
- Biotech Week
- Article date:
- October 14, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Algos Therapeutics Inc., a Minnesota-based global preclinical contract research organization (CRO) announces the selection of Dr. Ganesh Iyer as its new president and CEO. Dr. Iyer will assume his new responsibilities immediately (see also Algos Preclinical Services).
"We were incredibly fortunate to have attracted such a uniquely qualified executive as Dr. Iyer to lead Algos," stated Gary Smaby, Algos Board Chair and managing partner for Quatris Fund, the Company's lead investor. "Dr. Iyer possesses the rare combination of scientific expertise and business acumen needed to lead Algos in the deployment of the Company's new service-based CRO model focused on ...